EUVIMEDEUVIMED entdecken
Crossref

Defect‐Engineering Bismuth‐Based Homologous Schottky Heterojunction for Metabolic Regulation‐Augmented Sonodynamic Tumor Therapy

Xinyue Cao, Ying Wang, Xinran Song, Wanqing Lou, Xiaoyan Li, Weiping Lu, Kai Chen, Liang Chen, Yu Chen, Bingcang Huang

Advanced Functional Materials · 2023-06 · 33 (25)

DOI: 10.1002/adfm.202300777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 16.03.2023. Verfasst von Xinyue Cao und 9 weiteren Autor:innen. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Shuguang Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy demonstrates tremendous potential in biomedicine due to its non‐invasiveness, deep tissue penetration, and spatiotemporal controllability. However, the lack of favorable nanosonosensitizers with prominent reactive oxygen species generation capability and green chemical constituents remains a significant challenge for its broad biomedical applications. Herein, a homologous bismuth‐based nanosonosensitizer (Bi‐HJ) is designed and fabricated by direct defect engineering for combinational tumor therapy. Specifically, self‐derived Schottky heterojunction and oxygen vacancies are concurrently constructed in Bi‐HJ, which prominently promotes the separation of ultrasound‐triggered electron–hole pairs and improves the charge utilization efficiency. With the porous structure, Bi‐HJ is loaded with a metabolic regulation drug atovaquone to block the mitochondrial respiration for oxygen‐economized sonodynamic tumor suppression. The strong near‐infrared absorption of Bi‐HJ imparted by oxygen vacancies allows the implementation of photothermal therapy. Accordingly, Bi‐HJ rationally combines two therapeutic modalities and metabolic regulation function, as well as computed tomography imaging ability, thus achieving effective tumor theranostics in vitro and in vivo. Therefore, this study provides new insight into the fabrication of homologous nanosonosensitizers without the introduction of other constituents for synergistically enhanced tumor therapy.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Shuguang Program

Zitieren

APA

Cao, X., Wang, Y., Song, X., Lou, W., Li, X., Lu, W., Chen, K., Chen, L., Chen, Y., & Huang, B. (2023). Defect‐Engineering Bismuth‐Based Homologous Schottky Heterojunction for Metabolic Regulation‐Augmented Sonodynamic Tumor Therapy. Advanced Functional Materials, 33(25). https://doi.org/10.1002/adfm.202300777

Vancouver

Cao X, Wang Y, Song X, Lou W, Li X, Lu W, et al. Defect‐Engineering Bismuth‐Based Homologous Schottky Heterojunction for Metabolic Regulation‐Augmented Sonodynamic Tumor Therapy. Advanced Functional Materials. 2023;33(25). doi:10.1002/adfm.202300777

BibTeX
@article{Cao2023,
  author = {Cao, Xinyue and Wang, Ying and Song, Xinran and Lou, Wanqing and Li, Xiaoyan and Lu, Weiping and Chen, Kai and Chen, Liang and Chen, Yu and Huang, Bingcang},
  title = {Defect‐Engineering Bismuth‐Based Homologous Schottky Heterojunction for Metabolic Regulation‐Augmented Sonodynamic Tumor Therapy},
  journal = {Advanced Functional Materials},
  year = {2023},
  volume = {33},
  number = {25},
  doi = {10.1002/adfm.202300777}
}
Kostenlos starten →